KBSXKBSXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-11.8%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-11.8%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202511.08%
2024-15.23%
20231.46%
2022-0.86%
202116.12%
202020.74%
2019-0.73%
201828.32%
2017108.07%
2016236.06%